Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CODEL: Temozolomide vs PCV with Radiotherapy in 1p/19q Co-deleted Glioma
NCT00887146Phase 3Active, not recruiting
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2009
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of temozolomide in anaplastic glioma and glioma, sponsored by Cancer and Leukemia Group B. Started Sep 2009; status: active, not recruiting.
02
Drugs
temozolomide
03
Conditions
anaplastic gliomaglioma
Beyond the preview
Go deeper on NCT00887146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887146.